Close Menu

NEW YORK (GenomeWeb News) — Oligomerix said today that it has received a $323,000 grant from the National Institutes of Health's National Institute on Aging for research that could lead to diagnostic assays for Alzheimer's disease.

The New York, NY-based company plans to use the Small Business Innovation Research funding to develop a test that could monitor proteins in cerebrospinal fluid and plasma from AD patients. This research will be conducted by researchers at Columbia University Medical Center.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.